A further 8 million SEK to support clinical studies relating to COVID-19
The six regional nodes within Clinical Studies Sweden will receive an additional 8 million SEK in total, or 1.3 million SEK each, to further expand their abilities to support clinical studies linked to COVID-19.
Earlier this year, the regional nodes within Clinical Studies Sweden received a total of 12 million SEK from the Swedish Research Council. Now they will receive a further 8 million SEK to support clinical studies linked to COVID-19.
The initiative follows from the Swedish Research Council’s mandate to temporarily reinforce the activities within Clinical Studies Sweden to increase the opportunities for clinical researchers in Sweden to conduct clinical studies linked to the disease COVID-19. The funding is part of the 100 million SEK that the Swedish Research Council, in collaboration with Vinnova, has to allocate to research and innovation that can contribute to stopping the spread of COVID-19 and preventing future pandemic outbreaks.
The regional nodes offer various types of support to researchers in their work on clinical studies. Examples include help with study protocols, permit applications, data management and education.
Government mandate relating to clinical studies and COVID-19
Pdf / Printout
MORE WITHIN THE SAME SUBJECT AREA
Published 29 November 2021
The Swedish Research Council arrange a seminar on the upcoming evaluation of the quality of clinical research conducted in the regions that are subject to the ALF agreement. The purpose of the seminar is to inform about the upcoming evaluation. The r...
Published 19 November 2021
We have now decided on the dates for 40 or our calls next year. Many of calls are recurrent, but some will be issued for the first time. The new calls are shown in the list below. More calls will be added.
Published 15 November 2021
The Swedish Research Council is allocating 50 million SEK to 14 research projects into post-COVID syndrome. The research shall contribute to developing knowledge within health and medical care, and improving diagnosis and therapy alternatives for pat...